PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · IEX Real-Time Price · USD
25.32
+0.63 (2.55%)
At close: Apr 19, 2024, 4:00 PM
24.92
-0.40 (-1.58%)
After-hours: Apr 19, 2024, 4:15 PM EDT
PTC Therapeutics Market Cap
PTC Therapeutics has a market cap or net worth of $1.94 billion as of April 19, 2024. Its market cap has decreased by -45.29% in one year.
Market Cap
1.94B
Enterprise Value
1.48B
1-Year Change
-45.29%
Ranking
Category
Stock Price
$25.32
Market Cap Chart
Since June 20, 2013, PTC Therapeutics's market cap has increased from $366.20M to $1.94B, an increase of 429.69%. That is a compound annual growth rate of 16.63%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 1.89B | -1.87% |
Apr 17, 2024 | 1.93B | -0.51% |
Apr 16, 2024 | 1.94B | -1.52% |
Apr 15, 2024 | 1.97B | -2.80% |
Apr 12, 2024 | 2.02B | -3.58% |
Apr 11, 2024 | 2.10B | 1.82% |
Apr 10, 2024 | 2.06B | -2.50% |
Apr 9, 2024 | 2.11B | 2.68% |
Apr 8, 2024 | 2.06B | -0.52% |
Apr 5, 2024 | 2.07B | -2.88% |
Apr 4, 2024 | 2.13B | -4.07% |
Apr 3, 2024 | 2.22B | 2.11% |
Apr 2, 2024 | 2.18B | -0.66% |
Apr 1, 2024 | 2.19B | -1.72% |
Mar 28, 2024 | 2.23B | -1.19% |
Mar 27, 2024 | 2.26B | 5.29% |
Mar 26, 2024 | 2.14B | -3.12% |
Mar 25, 2024 | 2.21B | -0.79% |
Mar 22, 2024 | 2.23B | -3.58% |
Mar 21, 2024 | 2.31B | 2.24% |
Mar 20, 2024 | 2.26B | -3.02% |
Mar 19, 2024 | 2.33B | 4.90% |
Mar 18, 2024 | 2.22B | -1.83% |
Mar 15, 2024 | 2.26B | 2.29% |
Mar 14, 2024 | 2.21B | -6.17% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Tandem Diabetes Care | 2.00B |
Beam Therapeutics | 1.99B |
Dyne Therapeutics | 1.92B |
RxSight | 1.91B |
Galapagos NV | 1.91B |
Amphastar Pharmaceuticals | 1.86B |
Owens & Minor | 1.84B |
Avidity Biosciences | 1.84B |